Cito Capital Group, LLC Recursion Pharmaceuticals, Inc. Transaction History
Cito Capital Group, LLC
- $258 Million
- Q2 2024
A detailed history of Cito Capital Group, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 77,000 shares of RXRX stock, worth $511,280. This represents 0.22% of its overall portfolio holdings.
Number of Shares
77,000Holding current value
$511,280% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
291Shares Held
241MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$218 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$168 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$115 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$102 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.2B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...